Skip to main content
Clinical Trials/JPRN-UMIN000045021
JPRN-UMIN000045021
Completed
未知

A multicenter retrospective observational study of effectiveness of mepolizumab in patients with severe eosinophilic asthma and comorbidities in Japan (J-Real-Mepo) - J-Real-Mepo

Teikyo University School of Medicine0 sites200 target enrollmentJuly 31, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Teikyo University School of Medicine
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 31, 2021
End Date
February 28, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Teikyo University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) There is a significant lack of information recorded in the medical record. 2\) Some or all mepolizumab treatments were performed outside the study site 3\) Other than the above, the principal investigator subinvestigator judged the participation in the study to be inappropriate.

Outcomes

Primary Outcomes

Not specified

Similar Trials